Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo

被引:45
作者
White, SJ [1 ]
Page, SM [1 ]
Margaritis, P [1 ]
Brownlee, GG [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Chem Pathol Unit, Oxford OX1 3RE, England
基金
英国惠康基金;
关键词
D O I
10.1089/hum.1998.9.8-1187
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A persistent obstacle that has hampered gene transfer experiments is the short-term nature of transgene expression in vivo. In this article we present evidence for sustained expression from primary human keratinocytes, using the retroviral vector MFG, Primary keratinocytes were transduced in culture with the MFG retroviral vector containing the coding region from factor IX cDNA, Transduced keratinocytes, which secreted on average 830 ng of factor IX/10(6) cells/24 hr in tissue culture, were used to form a bilayered skin equivalent and grafted onto nude mice under a silicone transplantation chamber. Between 0.1 and 2.75 ng of human factor IX per milliliter was found in mouse plasma for more than 1 year, suggesting that keratinocyte stem cells were both transduced and grafted. The results show, for the first time, that long-term expression is obtainable in retrovirally transduced keratinocytes after transplantation.
引用
收藏
页码:1187 / 1195
页数:9
相关论文
共 45 条
[1]   CIRCULATING HUMAN FACTOR-IX PRODUCED IN KERATIN PROMOTER TRANSGENIC MICE - A FEASIBILITY STUDY FOR GENE-THERAPY OF HEMOPHILIA-B [J].
ALEXANDER, MY ;
BIDICHANDANI, SI ;
COUSINS, FM ;
ROBINSON, CJM ;
DUFFIE, E ;
AKHURST, RJ .
HUMAN MOLECULAR GENETICS, 1995, 4 (06) :993-999
[2]   THE GENE STRUCTURE OF HUMAN ANTI-HEMOPHILIC FACTOR-IX [J].
ANSON, DS ;
CHOO, KH ;
REES, DJG ;
GIANNELLI, F ;
GOULD, K ;
HUDDLESTON, JA ;
BROWNLEE, GG .
EMBO JOURNAL, 1984, 3 (05) :1053-1060
[3]   EXPRESSION OF ACTIVE HUMAN CLOTTING FACTOR-IX FROM RECOMBINANT DNA CLONES IN MAMMALIAN-CELLS [J].
ANSON, DS ;
AUSTEN, DEG ;
BROWNLEE, GG .
NATURE, 1985, 315 (6021) :683-685
[4]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[5]   PRODUCTION OF A TISSUE-LIKE STRUCTURE BY CONTRACTION OF COLLAGEN LATTICES BY HUMAN-FIBROBLASTS OF DIFFERENT PROLIFERATIVE POTENTIAL INVITRO [J].
BELL, E ;
IVARSSON, B ;
MERRILL, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1274-1278
[6]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[7]   MESENCHYME-MEDIATED AND ENDOGENOUS REGULATION OF GROWTH AND DIFFERENTIATION OF HUMAN SKIN KERATINOCYTES DERIVED FROM DIFFERENT BODY SITES [J].
BOUKAMP, P ;
BREITKREUTZ, D ;
STARK, HJ ;
FUSENIG, NE .
DIFFERENTIATION, 1990, 44 (02) :150-161
[8]   PROSPECTS FOR GENE-THERAPY OF HEMOPHILIA-A AND HEMOPHILIA-B [J].
BROWNLEE, GG .
BRITISH MEDICAL BULLETIN, 1995, 51 (01) :91-105
[9]   Sustainability of keratinocyte gene transfer and cell survival in vivo [J].
Choate, KA ;
Khavari, PA .
HUMAN GENE THERAPY, 1997, 8 (08) :895-901
[10]   Corrective gene transfer in the human skin disorder lamellar ichthyosis [J].
Choate, KA ;
Medalie, DA ;
Morgan, JR ;
Khavari, PA .
NATURE MEDICINE, 1996, 2 (11) :1263-1267